chr3-184346596-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_004366.6(CLCN2):c.*10G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0117 in 1,613,700 control chromosomes in the GnomAD database, including 152 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0087 ( 14 hom., cov: 32)
Exomes 𝑓: 0.012 ( 138 hom. )
Consequence
CLCN2
NM_004366.6 3_prime_UTR
NM_004366.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.28
Genes affected
CLCN2 (HGNC:2020): (chloride voltage-gated channel 2) This gene encodes a voltage-gated chloride channel. The encoded protein is a transmembrane protein that maintains chloride ion homeostasis in various cells. Defects in this gene may be a cause of certain epilepsies. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 3-184346596-C-T is Benign according to our data. Variant chr3-184346596-C-T is described in ClinVar as [Benign]. Clinvar id is 3038389.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00867 (1320/152290) while in subpopulation NFE AF= 0.0137 (934/68010). AF 95% confidence interval is 0.013. There are 14 homozygotes in gnomad4. There are 642 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1320 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCN2 | NM_004366.6 | c.*10G>A | 3_prime_UTR_variant | 24/24 | ENST00000265593.9 | NP_004357.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCN2 | ENST00000265593.9 | c.*10G>A | 3_prime_UTR_variant | 24/24 | 1 | NM_004366.6 | ENSP00000265593 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00869 AC: 1322AN: 152172Hom.: 14 Cov.: 32
GnomAD3 genomes
AF:
AC:
1322
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00889 AC: 2226AN: 250404Hom.: 18 AF XY: 0.00900 AC XY: 1219AN XY: 135464
GnomAD3 exomes
AF:
AC:
2226
AN:
250404
Hom.:
AF XY:
AC XY:
1219
AN XY:
135464
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0120 AC: 17559AN: 1461410Hom.: 138 Cov.: 31 AF XY: 0.0119 AC XY: 8616AN XY: 727032
GnomAD4 exome
AF:
AC:
17559
AN:
1461410
Hom.:
Cov.:
31
AF XY:
AC XY:
8616
AN XY:
727032
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00867 AC: 1320AN: 152290Hom.: 14 Cov.: 32 AF XY: 0.00862 AC XY: 642AN XY: 74448
GnomAD4 genome
AF:
AC:
1320
AN:
152290
Hom.:
Cov.:
32
AF XY:
AC XY:
642
AN XY:
74448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CLCN2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 05, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at